论文部分内容阅读
目的研究血浆输注对于协同治疗晚期肝癌患者常伴有的肝腹水、体内蛋白以及凝血因子大量缺失等病症的效果。方法本文以2008年2月至2008年9月天津市肿瘤医院收治的87例晚期肝细胞癌症患者为观测组,在进行内科常规治疗和介入治疗的同时对其进行血浆输注辅助治疗,血浆输注隔天1次,
Objective To investigate the effect of plasma infusion on the concurrent treatment of advanced liver cancer patients with liver ascites, in vivo protein and a large number of coagulation factors such as the effect of loss. Methods Totally 87 patients with advanced hepatocellular carcinoma who were treated in Tianjin Tumor Hospital from February 2008 to September 2008 were selected as the observation group. Plasma routine infusion and adjuvant therapy were carried out simultaneously with routine medical treatment and interventional therapy. Note once every other day,